Analysts warned that now that the European Central Bank had decided to use its veto on Greek bonds, a solution to the country’s debt crisis had to be found quickly.

A fall in Greek shares, sparked by the European Central Bank’s decision to stop accepting the country’s bonds, held back stock markets yesterday. A(...)

Bottles of AstraZeneca’s Nexium heartburn medication. Photographer: Daniel Acker/Bloomberg

AstraZeneca, the second-largest UK drug maker, said fourth-quarter earnings fell 33 per cent as revenue declined for two of its best-selling drugs and(...)

Pfizer has offered $90 per share in cash for Hospira Photograph: Reuters

Pharmaceutical giant Pfizer has offered to buy Hospira for about $15 billion (€13bn) to boost its portfolio of generic injectible drugs and biosimilar(...)

Scott McCauley, associate scientist at the Gilead Sciences, makes human proteins at the Gilead laboratory in Foster City, California. Photograph: David Paul Morris/Bloomberg

Anne Strange was too ill to dance at the evening reception when her daughter, Debbie, married in November but just being there was enough. The 63-year(...)

The company’s work on immune-boosting cancer treatments is advancing especially fast, chief executive Pascal Soriot said. Photograph: Bloomberg

AstraZeneca touted an “industry-leading” line-up of hot new cancer drugs as it looked to show investors it has a strong independent future just days b(...)

Virgin America president David Cush in the New York Stock Exchange yesterday before the company’s shares’ first day of trading. Photograph: Michael Loccisano/Getty Images

European stocks were little changed as slides in healthcare and commodity stocks offset gains in media companies.Eurostat, the EU’s official number c(...)

European Central Bank president Mario Draghi says policymakers are ready to implement further stimulus measures if needed. Photograph: Ints Kalnins/Reuters

Most stocks in Europe advanced as European Central Bank president Mario Draghi said policy makers are ready to implement further stimulus measures if(...)

Pfizer tightened its full-year earnings forecast to between $2.23 and $2.27 per share from its prior outlook of $2.20 to $2.30

Pfizer reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets(...)

AbbVie had recently said it was still committed to the deal, which would have reduced the reliance on its Humira drug, the world’s top selling arthritis medicine which loses US patent protection in 2016

Chicago-based AbbVie said it was reconsidering its $55 billion takeover of Dublin-headquartered Shire weeks after the USgovernment moved to curb dea(...)

In London, airline stocks such as British Airways owner IAG, easyJet, cruise operator Carnival, tour operator TUI Travel and Intercontinental Hotels Group were among the top decliners on the FTSE 100 index. Photograph: Mark Wilson/Getty Images

Global equities prices fell yesterday and oil slipped to near 27-month lows as the International Monetary Fund cut its outlook for global growth and (...)